A settlement provides a massive windfall for Arbutus and Roivant and avoids a worst-case scenario for Moderna.
This story has been updated.
Moderna has agreed to pay Roivant up to $2.25 billion to settle claims that the mRNA vaccine developer infringed on Roivant’s patents in its Covid-19 shot.
Roivant will receive $950 million and then another $1.3 billion if Moderna’s attempts to have parts of its liability offloaded to the federal government fail upon appeal. If the full amount is paid, it will be among the largest patent settlements in history.
Continue to STAT+ to read the full story…
— Source: STAT News (https://www.statnews.com/2026/03/03/moderna-settles-covid-vaccine-suit-roivant/)
